All News

Found 3,193 articles

• Immunomedics, Inc. Reports Preclinical Results On SN-38 Antibody-Drug Conjugates As A Potential Novel Platform For Treating Cancer

  4/8/2014

• Sorrento Therapeutics, Inc. Appoints Ian Walters As Senior Vice President Of Translational Medicine And Corporate Development

  4/8/2014

• Mersana Therapeutics, Inc. Enters Collaboration With Takeda Pharmaceutical Co. Ltd. To Develop Next-Generation Antibody-Drug Conjugates

  4/7/2014

• Sorrento Therapeutics, Inc. Announces Presentation Of Data From Clinical Study Of Resiniferatoxin For Intractable Cancer Pain At ASRA Meeting

  4/4/2014

• Sorrento Therapeutics, Inc. Announces Key Presentation On Cynviloq At The American Association for Cancer Research Annual Meeting

  4/4/2014

• Celldex Therapeutics, Inc. To Present Antibody-Drug Conjugate CDX-014 Preclinical Proof Of Concept Data At American Association for Cancer Research 2014

  4/3/2014

• Mersana Therapeutics, Inc. Awarded Patent With Broad Coverage For Fleximer-ADC Platform Technology

  4/2/2014

• ImmunoGen, Inc. Announces Presentations By Company Scientists At Upcoming American Association for Cancer Research Annual Meeting

  3/17/2014

• Sorrento Therapeutics, Inc. Appoints Mark Durand To Its Board Of Directors

  3/11/2014

• Sorrento Therapeutics, Inc. Announces Three Presentations And A Satellite Symposium On Cynviloq™ At The 31st Annual Miami Breast Cancer Conference

  3/6/2014

• Sorrento Therapeutics, Inc. To Present At ROTH Capital Partners 26th Annual Growth Stock Conference

  3/6/2014

• Sorrento Therapeutics, Inc. Hires Mike Royal As Senior Vice President Of Clinical Development

  3/3/2014

• ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences

  2/28/2014

• Sheila Gujrathi, M.D., Joins Ambrx, Inc. Board Of Directors

  2/24/2014

• NBE-Therapeutics Announces Successful Validation Of Its SMAC™-Technology For The Generation Of Antibody Drug Conjugates (ADCs)

  2/21/2014

• BCC Research Publishes New Report On Global Market For Antibody Drug Conjugates

  2/20/2014

• BioOutsource Expands ADC Characterisation Capabilities

  2/18/2014

• Sorrento Therapeutics, Inc. Expands Its Exclusive Rights To Cynviloq™ To Include Australia, Canada And Mexico

  2/10/2014

• Sorrento Therapeutics, Inc. Announces Two Presentations On Cynviloq™ At The Beaujon International Conference On "Cutting Edge In Liver And Pancreatic Tumors"

  2/10/2014

• ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences

  2/7/2014